Literature DB >> 2555007

Angiotensin converting enzyme activity is present in the endothelium-denuded aorta.

E Pipili1, V G Manolopoulos, J D Catravas, M E Maragoudakis.   

Abstract

Angiotensin converting enzyme activity was measured in intact aortic rings utilizing the synthetic tripeptide [3H]-benzoyl-Phe-Ala-Pro as the substrate. Intact aortic rings possessed angiotensin converting enzyme activity which was blocked by captopril. Enzyme activity was reduced by approximately 30% after removal of the endothelium by chemical or mechanical methods. The remaining activity was also captopril-sensitive. These results suggest that in addition to endothelium, angiotensin converting enzyme activity is present in other vascular cells and may contribute to the metabolism of angiotensin I generated within the vessel wall.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2555007      PMCID: PMC1854739          DOI: 10.1111/j.1476-5381.1989.tb12599.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  12 in total

Review 1.  Significance of the vascular renin-angiotensin pathway.

Authors:  V J Dzau
Journal:  Hypertension       Date:  1986-07       Impact factor: 10.190

2.  Detection of endothelium in cerebral blood vessels.

Authors:  R P Abrol; V M Hughes; C A Krueger; D A Cook
Journal:  J Pharmacol Methods       Date:  1984-10

3.  Localization of angiotensin converting enzyme (kininase II). II. Immunocytochemistry and immunofluorescence.

Authors:  U S Ryan; J W Ryan; C Whitaker; A Chiu
Journal:  Tissue Cell       Date:  1976       Impact factor: 2.466

4.  Angiotensin-converting enzyme: vascular endothelial localization.

Authors:  P R Caldwell; B C Seegal; K C Hsu; M Das; R L Soffer
Journal:  Science       Date:  1976-03-12       Impact factor: 47.728

5.  Involvement of the vascular renin-angiotensin system in beta adrenergic receptor-mediated facilitation of vascular neurotransmission in spontaneously hypertensive rats.

Authors:  H Kawasaki; W H Cline; C Su
Journal:  J Pharmacol Exp Ther       Date:  1984-10       Impact factor: 4.030

6.  Plasmalemmal metabolic activities in cultured calf pulmonary arterial endothelial cells.

Authors:  J D Catravas; C A Watkins
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1985-11

7.  Angiotensin I-converting enzyme localization on cultured fibroblasts by immunofluorescence.

Authors:  K S Weinberg; W H Douglas; D R MacNamee; J J Lanzillo; B L Fanburg
Journal:  In Vitro       Date:  1982-04

8.  Angiotensin-converting enzyme substrates hydrolyzed by fibroblasts and vascular endothelial cells.

Authors:  D B Rubin; R J Mason; L J Dobbs
Journal:  Exp Lung Res       Date:  1982-05       Impact factor: 2.459

9.  Renin substrate in rat mesenteric artery.

Authors:  S Desjardins-Giasson; J Gutkowska; R Garcia; J Genest
Journal:  Can J Physiol Pharmacol       Date:  1981-06       Impact factor: 2.273

10.  The histological distribution of blood group substances A and B in man.

Authors:  A E SZULMAN
Journal:  J Exp Med       Date:  1960-06-01       Impact factor: 14.307

View more
  5 in total

Review 1.  Tissue and plasma angiotensin converting enzyme and the response to ACE inhibitor drugs.

Authors:  R J MacFadyen; K R Lees; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1991-01       Impact factor: 4.335

2.  Effects of angiotensin I and angiotensin II in blood vessels: greater influence of converting enzyme activity in the rabbit basilar artery.

Authors:  A Zerrouk; M Auguet; S Delaflotte; P E Chabrier
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-10       Impact factor: 3.000

3.  Demonstration of extrapulmonary activity of angiotensin converting enzyme in intact tissue preparations.

Authors:  F Lembeck; T Griesbacher; M Eckhardt
Journal:  Br J Pharmacol       Date:  1990-05       Impact factor: 8.739

4.  Cyclic AMP selectively enhances bradykinin receptor synthesis and expression in cultured arterial smooth muscle. Inhibition of angiotensin II and vasopressin response.

Authors:  B S Dixon
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

5.  Contributions of leukocyte angiotensin-converting enzyme to development of atherosclerosis.

Authors:  Xiaofeng Chen; Hong Lu; Mingming Zhao; Katsuya Tashiro; Lisa A Cassis; Alan Daugherty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-07-11       Impact factor: 8.311

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.